Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Debt / NOTE 4.000% 4/0
-
Market price (% of par)
-
91.53%
-
Total 13F principal
-
$92,413,050
-
Principal change
-
+$84,543,000
-
Total reported market value
-
$102,285,000
-
Number of holders
-
9
-
Value change
-
+$77,481,000
-
Number of buys
-
7
Institutional Holders of TRINITY BIOTECH INVT LTD - NOTE 4.000% 4/0 as of Q2 2016
As of 30 Jun 2016,
TRINITY BIOTECH INVT LTD - NOTE 4.000% 4/0 was held by
9 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$92,413,050
in principal (par value) of the bond.
The largest 9 bondholders included
DEERFIELD MANAGEMENT CO, HIGHBRIDGE CAPITAL MANAGEMENT LLC, WOLVERINE ASSET MANAGEMENT LLC, Park West Asset Management LLC, CITADEL ADVISORS LLC, GABELLI FUNDS LLC, PALISADE CAPITAL MANAGEMENT LLC/NJ, Pine River Capital Management L.P., and Wellesley Investment Advisors.
This page lists
9
institutional bondholders reporting positions
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.